Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Operating Expenses | 2,647 | 2,716 | 2,876 | 2,436 | 3,003 |
| Operating Income | -2,647 | -2,716 | -2,876 | -2,436 | -3,003 |
| Other Income | 111 | 131 | 154 | 156 | 190 |
| Pre-tax Income | -2,536 | -2,585 | -2,722 | -2,280 | -2,813 |
| Net Income Continuous | -2,536 | -2,585 | -2,722 | -2,280 | -2,813 |
| Minority Interests | -20 | -20 | -27 | -22 | -23 |
| Net Income | $-2,516 | $-2,565 | $-2,695 | $-2,258 | $-2,790 |
| EPS Basic Total Ops | -0.07 | -0.08 | -0.08 | -0.07 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.08 | -0.07 | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.08 | -0.08 | -0.07 | -0.09 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.08 | -0.07 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.08 | -0.09 | -0.07 | -0.09 |
| EBITDA(a) | $-2,613 | $-2,659 | $-2,917 | $-2,441 | $-2,821 |